drugset / Trial / NCT00333567
Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to investigate the efficacy and safety of a single daily dose of 400 mg lumiracoxib given pre-emptively versus post-operatively in terms of efficacy in reducing pain associated with ambulatory arthroscopic knee surgery
Timeline
- Start
- 2006-08
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lumiracoxib | Small molecule | 400 mg | — |
Indications
No indication recorded.